BeyondSpring is trading 6.6% down at $1.56, pulling back after a short rebound that followed its removal from the Russell 3000E Growth Benchmark and executive leadership changes effective July 1, 2026.
- The stock had previously traded approximately 6.3% higher in pre-market as investors reacted to the leadership transition and updates regarding the Plinabulin clinical program.
- No fresh company-specific news has emerged to explain today’s decline, suggesting the move is a result of normal volatility following the initial reaction to recent developments.